Literature DB >> 26194256

Non-alcoholic fatty liver disease resolution following sleeve gastrectomy.

Ardeshir Algooneh1, Sulaiman Almazeedi1, Salman Al-Sabah2, Maha Ahmed3, Feras Othman1.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD), a disease highly prevalent among the morbidly obese population, is one of the most common causes of chronic liver disease today. The purpose of this study was to observe the effect of laparoscopic sleeve gastrectomy (LSG) on the resolution of NAFLD.
METHODS: A retrospective study was conducted of 84 patients diagnosed with NAFLD prior to undergoing LSG. The diagnosis of NAFLD was achieved based on transabdominal ultrasonographic imaging as per the 2012 joint guidelines for the diagnosis of NAFLD (American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology). The patients had follow-up anthropometric measurements and were re-evaluated with postoperative ultrasounds at different time frames to assess the resolution of the disease.
RESULTS: The median age of the patients was 44 (17-62), and 66.7 % were female. Average time since surgery was 3.3 years (range 1-5 years). The mean pre- and postoperative BMIs were 46.6 ± 7.8 and 33.0 ± 7.1, respectively, with a mean percent excess weight loss (%EWL) of 55.7 % ± 23.0. A total of 47 (56 %) patients showed complete resolution of NAFLD postoperatively. Multivariate analysis showed a significant resolution of NAFLD in patients achieving >50 % EWL (OR 10.1; p < 0.001) after controlling for age and sex.
CONCLUSIONS: Weight loss after LSG effectively resolved NAFLD in more than half of the obese patients in this study and can prove to be a useful tool in tackling the disease in the future.

Entities:  

Keywords:  Bariatric; Metabolic surgery; NAFLD; Obesity; Sleeve gastrectomy

Mesh:

Year:  2015        PMID: 26194256     DOI: 10.1007/s00464-015-4426-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  24 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Kathryn Law; Elizabeth M Brunt
Journal:  Clin Liver Dis       Date:  2010-11       Impact factor: 6.126

Review 2.  Non-alcoholic fatty liver disease: a massive problem.

Authors:  Christopher P Day
Journal:  Clin Med (Lond)       Date:  2011-04       Impact factor: 2.659

Review 3.  GI epidemiology: nonalcoholic fatty liver disease.

Authors:  P Angulo
Journal:  Aliment Pharmacol Ther       Date:  2007-04-15       Impact factor: 8.171

4.  Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.

Authors:  Samer G Mattar; Laura M Velcu; Mordechai Rabinovitz; A J Demetris; A M Krasinskas; Emma Barinas-Mitchell; George M Eid; Ramesh Ramanathan; Debra S Taylor; Philip R Schauer
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

5.  Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis.

Authors:  Andrew A Taitano; Michael Markow; Jon E Finan; Donald E Wheeler; John Paul Gonzalvo; Michel M Murr
Journal:  J Gastrointest Surg       Date:  2014-12-24       Impact factor: 3.452

6.  Body mass index and all-cause mortality in a nationwide US cohort.

Authors:  D M Freedman; E Ron; R Ballard-Barbash; M M Doody; M S Linet
Journal:  Int J Obes (Lond)       Date:  2006-05       Impact factor: 5.095

Review 7.  Review article: hepatic steatosis and insulin resistance.

Authors:  A Lonardo; S Lombardini; M Ricchi; F Scaglioni; P Loria
Journal:  Aliment Pharmacol Ther       Date:  2005-11       Impact factor: 8.171

Review 8.  Nonalcoholic fatty liver disease.

Authors:  Marcin Krawczyk; Leonilde Bonfrate; Piero Portincasa
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-10       Impact factor: 3.043

9.  Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis.

Authors:  Guruprasad P Aithal; James A Thomas; Philip V Kaye; Adam Lawson; Stephen D Ryder; Ian Spendlove; Andrew S Austin; Jan G Freeman; Linda Morgan; Jonathan Webber
Journal:  Gastroenterology       Date:  2008-06-25       Impact factor: 22.682

Review 10.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more
  8 in total

1.  Prospective Longitudinal Trends in Body Composition and Clinical Outcomes 3 Years Following Sleeve Gastrectomy.

Authors:  Shiri Sherf-Dagan; Shira Zelber-Sagi; Assaf Buch; Nir Bar; Muriel Webb; Nasser Sakran; Asnat Raziel; David Goitein; Andrei Keidar; Oren Shibolet
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

2.  The Effect of Roux-En-Y vs. Omega Loop Gastric Bypass on Liver, Metabolic Parameters, and Weight Loss.

Authors:  A Hussain; S El-Hasani
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

3.  Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.

Authors:  Deepa V Cherla; Noe A Rodriguez; Roman Vangoitsenhoven; Tavankit Singh; Neal Mehta; Arthur J McCullough; Stacy A Brethauer; Philip R Schauer; Ali Aminian
Journal:  Surg Endosc       Date:  2019-07-29       Impact factor: 4.584

4.  Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model.

Authors:  Kiminori Watanabe; Masayuki Ohta; Hiroomi Takayama; Kazuhiro Tada; Yuki Shitomi; Takahide Kawasaki; Yuichiro Kawano; Yuichi Endo; Yukio Iwashita; Masafumi Inomata
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

Review 5.  Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease.

Authors:  Iraklis Perysinakis; Harilaos C Pappis; Elias Margaris
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

6.  Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.

Authors:  Felix Nickel; Christian Tapking; Laura Benner; Janina Sollors; Adrian T Billeter; Hannes G Kenngott; Loay Bokhary; Mathias Schmid; Moritz von Frankenberg; Lars Fischer; Sebastian Mueller; Beat P Müller-Stich
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

7.  BYPASS VS. SLEEVE AND ITS EFFECTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: WHAT IS THE BEST TECHNIQUE?

Authors:  Marcos Bertozzi Goldoni; Paulo Roberto Ott Fontes; Marcela Menuci GuimarÃes; João Alfredo Diedrich-Neto; Tiele Nogueira; Uirá Fernandes Teixeira; Caroline Becker Giacomazzi; Guillermo Kiss; Sérgio Ricardo Pioner; Pablo Duarte Rodrigues
Journal:  Arq Bras Cir Dig       Date:  2021-01-15

Review 8.  The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review.

Authors:  Milad Kheirvari; Nikta Dadkhah Nikroo; Habib Jaafarinejad; Marziye Farsimadan; Sahar Eshghjoo; Sara Hosseini; Taha Anbara
Journal:  Heliyon       Date:  2020-02-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.